Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-1287-5p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 325, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
UBR4 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:19165252-19165275 PAR-CLIP POSITIVE DIRECT TarBase 7.0
CHTF18 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr16:795154-795176 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ARHGAP22 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr10:48446344-48446363 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PRRC2B hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr9:131485032-131485059 HITS-CLIP POSITIVE DIRECT TarBase 7.0
C16orf13 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr16:634659-634683 HITS-CLIP POSITIVE DIRECT TarBase 7.0
THEMIS2 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:27882326-27882351 PAR-CLIP POSITIVE DIRECT TarBase 7.0
PSME3 hsa-miR-1287-5p low: 0 high: 1 1 1 1 0.495
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr17:42838117-42838141 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MCCC2 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr5:71656749-71656773 HITS-CLIP POSITIVE DIRECT TarBase 7.0
LLGL1 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr17:18242235-18242261 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NOTCH2 hsa-miR-1287-5p low: 0 high: 1 1 1 1 0.502
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:119914194-119914220 PAR-CLIP POSITIVE DIRECT TarBase 7.0
MDM2 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:68841397-68841424 PAR-CLIP POSITIVE DIRECT TarBase 7.0
TTYH3 hsa-miR-1287-5p low: 0 high: 1 1 1 1 0.636
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr7:2662310-2662338 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RSAD1 hsa-miR-1287-5p low: 0 high: 1 1 1 1 0.493
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr17:50485032-50485060 HITS-CLIP POSITIVE DIRECT TarBase 7.0
STX17 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr9:99968607-99968631 HITS-CLIP POSITIVE DIRECT TarBase 7.0
APTX hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr9:32984674-32984700 HITS-CLIP POSITIVE DIRECT TarBase 7.0
IRF4 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:401510-401534 PAR-CLIP POSITIVE DIRECT TarBase 7.0
IER3 hsa-miR-1287-5p low: 0 high: 1 1 1 1 0.911
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr6:30743398-30743420 HITS-CLIP POSITIVE DIRECT TarBase 7.0
VARS2 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr6:30925879-30925904 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CPEB2 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr4:15067546-15067565 PAR-CLIP POSITIVE DIRECT TarBase 7.0
NUMA1 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr11:72004738-72004761 HITS-CLIP POSITIVE DIRECT TarBase 7.0